NYSE: NXRTNexpoint Residential Trust Inc Stock
$39.25-0.36 (-0.91%)
Updated Jan 17, 2025
NXRT Price
$39.25
Fair Value Price
N/A
Market Cap
$997.09M
52 Week Low
$28.20
52 Week High
$48.37
P/E
21.81x
P/B
2.23x
P/S
4.22x
PEG
1.67x
Dividend Yield
4.83%
Revenue
$264.80M
Earnings
$46.39M
Gross Margin
65.5%
Operating Margin
40.64%
Profit Margin
17.5%
Debt to Equity
3.36
Operating Cash Flow
$82M
Beta
1.12
Next Earnings
Feb 18, 2025
Ex-Dividend
N/A
Next Dividend
N/A
NXRT Overview
NexPoint Residential Trust, a real estate investment trust (REIT) owns middle-income multifamily properties in large cities and suburban submarkets in the southeastern and southwestern U.S. The company allocates 30% of its resources to first and second mortgages and subordinated, bridge, mezzanine, and construction loans related to or secured by multifamily real estate. NexPoint was founded in 2014 and is headquartered in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NXRT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Value
F
Growth
C
Momentum
D
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Residential REIT
Industry Rating
F
NXRT
Ranked#16 of 20
Ranked#16 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.82 | C | |
| $18.28 | C | |
| $12.40 | C |
Be the first to know about important NXRT news, forecast changes, insider trades & much more!
NXRT News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NXRT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NXRT ($39.25) is trading above its intrinsic value of $17.34, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NXRT is good value based on its earnings relative to its share price (21.81x), compared to the US market average (30.45x)
P/E vs Market Valuation
NXRT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NXRT due diligence checks available for Premium users.
Valuation
NXRT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
21.81x
Industry
23.02x
Market
30.45x
NXRT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NXRT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NXRT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.23x
Industry
2.51x
NXRT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NXRT price to earnings growth (PEG)
For valuing profitable companies with growth potential
NXRT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
NXRT's financial health
Profit margin
Revenue
$64.1M
Net Income
-$8.9M
Profit Margin
-13.8%
NXRT's Earnings (EBIT) of $107.60M... subscribe to Premium to read more.
Interest Coverage Financials
NXRT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.0B
Liabilities
$1.5B
Debt to equity
3.36
NXRT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NXRT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$27.8M
Investing
-$9.9M
Financing
-$11.9M
NXRT's operating cash flow ($81.97M)... subscribe to Premium to read more.
Debt Coverage Financials
NXRT vs Residential REIT Stocks
Nexpoint Residential Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.